mTOR Inhibition: From Aging to Autism and Beyond

被引:40
作者
Kaeberlein, Matt [1 ]
机构
[1] Univ Washington, Dept Pathol, 1959 NE Pacific St,D 514, Seattle, WA 98195 USA
关键词
D O I
10.1155/2013/849186
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The mechanistic target of rapamycin (mTOR) is a highly conserved protein that regulates growth and proliferation in response to environmental and hormonal cues. Broadly speaking, organisms are constantly faced with the challenge of interpreting their environment and making a decision between "grow or do not grow." mTOR is a major component of the network that makes this decision at the cellular level and, to some extent, the tissue and organismal level as well. Although overly simplistic, this framework can be useful when considering the myriad functions ascribed to mTOR and the pleiotropic phenotypes associated with genetic or pharmacological modulation of mTOR signaling. In this review, I will consider mTOR function in this context and attempt to summarize and interpret the growing body of literature demonstrating interesting and varied effects of mTOR inhibitors. These include robust effects on a multitude of age-related parameters and pathologies, as well as several other processes not obviously linked to aging or age-related disease.
引用
收藏
页数:17
相关论文
共 259 条
[1]   P7170, a novel inhibitor of phosphoinositide 3-kinase (PI3K)-mammalian target of Rapamycin (mTOR) and activin receptor-like kinase 1 (ALK1) as a new therapeutic option for Kras mutated non small cell lung cancer (NSCLC) [J].
Agarwal, Veena R. ;
Joshi, Asavari ;
Venkataraman, Magesh ;
Bhatia, Dimple ;
Bose, Julie ;
Kolla, Lakshmi Sireesha ;
Gill, Parkash ;
Sharma, Somesh .
CANCER RESEARCH, 2012, 72
[2]   Inhibition of Mechanistic Target of Rapamycin Promotes Dendritic Cell Activation and Enhances Therapeutic Autologous Vaccination in Mice [J].
Amiel, Eyal ;
Everts, Bart ;
Freitas, Tori C. ;
King, Irah L. ;
Curtis, Jonathan D. ;
Pearce, Erika L. ;
Pearce, Edward J. .
JOURNAL OF IMMUNOLOGY, 2012, 189 (05) :2151-2158
[3]  
Anand S., 2013, J GERONTOLOGY
[4]   Rapamycin increases lifespan and inhibits spontaneous tumorigenesis in inbred female mice [J].
Anisimov, Vladimir N. ;
Zabezhinski, Mark A. ;
Popovich, Irina G. ;
Piskunova, Tatiana S. ;
Semenchenko, Anna V. ;
Tyndyk, Margarita L. ;
Yurova, Maria N. ;
Rosenfeld, Svetlana V. ;
Blagosklonny, Mikhail V. .
CELL CYCLE, 2011, 10 (24) :4230-4236
[5]   mTOR regulates memory CD8 T-cell differentiation [J].
Araki, Koichi ;
Turner, Alexandra P. ;
Shaffer, Virginia Oliva ;
Gangappa, Shivaprakash ;
Keller, Susanne A. ;
Bachmann, Martin F. ;
Larsen, Christian P. ;
Ahmed, Rafi .
NATURE, 2009, 460 (7251) :108-U124
[6]   Rapamycin inhibits the growth of glioblastoma [J].
Arcella, Antonietta ;
Biagioni, Francesca ;
Oliva, Maria Antonietta ;
Bucci, Domenico ;
Frati, Alessandro ;
Esposito, Vincenzo ;
Cantore, Giampaolo ;
Giangaspero, Felice ;
Fornai, Francesco .
BRAIN RESEARCH, 2013, 1495 :37-51
[7]   Safety and tolerability of AZD8055 in Japanese patients with advanced solid tumors; a dose-finding phase I study [J].
Asahina, Hajime ;
Nokihara, Hiroshi ;
Yamamoto, Noboru ;
Yamada, Yasuhide ;
Tamura, Yosuke ;
Honda, Kazunori ;
Seki, Yoshitaka ;
Tanabe, Yuko ;
Shimada, Hitoshi ;
Shi, Xiaojin ;
Tamura, Tomohide .
INVESTIGATIONAL NEW DRUGS, 2013, 31 (03) :677-684
[8]   It may be possible to delay the onset of neurodegenerative diseases with an immunosuppressive drug (rapamycin) [J].
Aso, Ester ;
Ferrer, Isidre .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2013, 13 (09) :1215-1219
[9]   Connecting mTORC1 signaling to SREBP-1 activation [J].
Bakan, Inan ;
Laplante, Mathieu .
CURRENT OPINION IN LIPIDOLOGY, 2012, 23 (03) :226-234
[10]   Evidence for Rapamycin Toxicity in Pancreatic β-Cells and a Review of the Underlying Molecular Mechanisms [J].
Barlow, Adam D. ;
Nicholson, Michael L. ;
Herbert, Terry P. .
DIABETES, 2013, 62 (08) :2674-2682